Cilostazol is a unique platelet inhibitor that has been used clinically for more than 20 years. As a phosphodiesterase type III inhibitor, cilostazol is capable of reversible inhibition of platelet aggregation and vasodilation, has antiproliferative effects, and is widely used in the treatment of peripheral arterial disease, cerebrovascular disease, percutaneous coronary intervention, etc. This article briefly reviews the pharmacological mechanisms and clinical application of cilostazol.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/1568026619666191122123855 | DOI Listing |
Publication Analysis
Top Keywords
clinical application
8
application cilostazol
8
progress mechanism
4
mechanism clinical
4
cilostazol
4
cilostazol cilostazol
4
cilostazol unique
4
unique platelet
4
platelet inhibitor
4
inhibitor clinically
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!